3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Prostatic Neoplasms
47
Breast Neoplasms
34
Breast Neoplasms, Male
3
Neoplasms
2
Neoplasm Metastasis
2
Infertility
2
Advanced Breast Cancer
2
Sexual Dysfunction, Physiological
1
Recurrence
1
Prostate Adenocarcinoma
1
Primary Ovarian Insufficiency
1
Osteoporosis
1
Osteitis Deformans
1
Leiomyoma
1
Hot Flashes
1
Hemorrhage
1
Breast Cancer Invasive
1
Anemia
1
Advanced Prostate Cancer
1
Advanced Metastatic Breast Cancer
1
Interventions
Gabapentin
3
liposomal amphotericin B
2
oxybutynin
1
fezolinetant
1
black cohosh root extract
1
Venlafaxine Hydrochloride
1
Vancomycin
1
Testosterone
1
Tazobactam
1
Tamoxifen
1
Tablets
1
Sugars
1
Soybean Proteins
1
Pregabalin
1
Piperacillin, Tazobactam Drug Combination
1
Piperacillin
1
Mind-Body Therapies
1
Megestrol Acetate
1
Medroxyprogesterone
1
Linseed Oil
1
Levofloxacin
1
Isoflavones
1
Hypnosis
1
Goserelin
1
Folic Acid
1
Filgrastim
1
Estrogens, Conjugated (USP)
1
Estradiol
1
Cyproterone Acetate
1
Citalopram
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Hot Flashes
×
Goserelin
×
Clear all
NCT00303784
2020-11-27
PATCH
University College, London
Phase 3
Unknown
2,200 enrolled